This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jun;16(6):410-411.

doi: 10.1016/S1474-4422(17)30126-6. Epub 2017 Apr 28.

Challenging chronic migraine: targeting the CGRP receptor

Maria Adele Giamberardino¹, Raffaele Costantini²

Affiliations

Affiliations

¹ Headache Center, Department of Medicine and Science of Aging, and Center on Aging Science and Translational Medicine, G D'Annunzio University of Chieti, 66100 Chieti, Italy. Electronic address: mag@unich.it.
² Institute of Surgical Pathology, Department of Medical, Oral and Biotechnological Sciences, G D'Annunzio University of Chieti, 66100 Chieti, Italy.

PMID: 28460891
DOI: 10.1016/S1474-4422(17)30126-6

Comment

Challenging chronic migraine: targeting the CGRP receptor

Maria Adele Giamberardino et al. Lancet Neurol. 2017 Jun.

. 2017 Jun;16(6):410-411.

doi: 10.1016/S1474-4422(17)30126-6. Epub 2017 Apr 28.

Authors

Maria Adele Giamberardino¹, Raffaele Costantini²

Affiliations

¹ Headache Center, Department of Medicine and Science of Aging, and Center on Aging Science and Translational Medicine, G D'Annunzio University of Chieti, 66100 Chieti, Italy. Electronic address: mag@unich.it.
² Institute of Surgical Pathology, Department of Medical, Oral and Biotechnological Sciences, G D'Annunzio University of Chieti, 66100 Chieti, Italy.

PMID: 28460891
DOI: 10.1016/S1474-4422(17)30126-6

No abstract available

PubMed Disclaimer

Comment on

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
Tepper S, Ashina M, Reuter U, Brandes JL, Doležil D, Silberstein S, Winner P, Leonardi D, Mikol D, Lenz R. Tepper S, et al. Lancet Neurol. 2017 Jun;16(6):425-434. doi: 10.1016/S1474-4422(17)30083-2. Epub 2017 Apr 28. Lancet Neurol. 2017. PMID: 28460892 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program